In 2023, the FDA placed approximately 1719 peptides on the Category 2 restricted list citing safety concerns: potential carcinogenicity, immunogenicity risk, organ toxicity, and a lack of clinical trial data in humans
Learn more about our Vitamin Injection Therapy services here
Add 2 ml of bacteriostatic water to the 50 mg vial
while neither compound is known to impair lactation, the concentrated doses delivered by weekly injections may alter milk taste or infant gastrointestinal tolerance
LL-37 (5mg) LL-37 Peptide 5mg (Lyophilized Peptide in 3ml Vial) For Research Use Only LL-37 is a human antimicrobial peptide derived from the cathelicidin family, extensively studied for its roles in innate immunity, antimicrobial defense, wound healing, and inflammation regulation